NCT07201259View on ClinicalTrials.gov

Exploring Gut Microbiome Differences in Female Cancer Patients With Varied Ovarian Function and Fertility Outcomes Following Immune Checkpoint Inhibitor Therapy

Not yet recruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

October 10, 2025

Primary Completion Date

July 10, 2026

Study Completion Date

October 10, 2026

Conditions
Malignant Tumors
Interventions
OTHER

No Intervention: Observational Cohort

No Intervention: Observational Cohort

Trial Locations (1)

610041

West China Hospital, Chengdu

All Listed Sponsors
lead

West China Second University Hospital

OTHER

NCT07201259 - Exploring Gut Microbiome Differences in Female Cancer Patients With Varied Ovarian Function and Fertility Outcomes Following Immune Checkpoint Inhibitor Therapy | Biotech Hunter | Biotech Hunter